睡眠质量与心脑血管疾病发病中、低危人群颈动脉粥样硬化的相关性分析
|
|
赵倩, 王颖, 谢依热·哈木拉提, 古丽洁合热·吐尔逊, 李晓梅, 杨毅宁
|
Correlation analysis between sleep quality and carotid atherosclerosis in low and moderate risk individuals for cardiovascular and cerebrovascular diseases
|
|
ZHAO Qian, WANG Ying, HAMULATI Xieyire, TUERXUN Gulijiehere, LI Xiaomei, YANG Yining
|
|
表1 心脑血管疾病发病中、低危人群颈动脉粥样硬化一般情况分析
|
Tab 1 Baseline analysis of carotid atherosclerosis in low and moderate risk individuals for cardiovascular and cerebrovascular diseases
|
|
| Characteristic variable | Total (n=1 528) | Carotid intima-media thickening/plaque formation (n=732) | Normal intima-media thickness (n=796) | t/z/χ2 value | P value |
|---|
| Male/n(%) | 685 (44.8) | 359 (49.0) | 326 (40.9) | 10.088 | 0.001 | | Age/year | 49.4±8.2 | 52.4±7.4 | 46.6±7.9 | 14.948 | 0.000 | | Bachelor′s degree or above/n(%) | 1 237 (81.0) | 558 (76.2) | 679 (85.4) | 20.872 | 0.000 | | BMI/(kg·m-2) | 25.1±3.5 | 25.3±3.4 | 24.9±3.5 | 2.276 | 0.022 | | Obesity/n(%) | 283 (18.5) | 142 (19.4) | 141 (17.7) | 0.717 | 0.397 | | Waist circumference/cm | 83.8±10.5 | 84.9±9.8 | 82.7±10.9 | 4.064 | 0.000 | | Abdominal obesity/n(%) | 714 (46.7) | 361 (49.3) | 353 (44.3) | 3.884 | 0.049 | | Diabetes/n(%) | 60 (3.9) | 40 (5.5) | 20 (2.5) | 8.808 | 0.003 | | SBP/mmHg | 126.3±15.2 | 128.7±15.3 | 124.1±14.9 | 5.941 | 0.000 | | DBP/mmHg | 79.4±10.9 | 78.7±10.8 | 80.2±10.9 | 2.613 | 0.009 | | High bloodpressure/n(%) | 707 (46.3) | 377 (51.5) | 330 (41.4) | 15.478 | 0.000 | | TAG/(mmol·L-1) | 1.33 (0.95, 1.95) | 1.44 (1.06, 2.04) | 1.24 (0.89, 1.85) | 5.342 | 0.000 | | TC/(mmol·L-1) | 5.03±0.98 | 5.18±1.02 | 4.90±0.93 | 5.621 | 0.000 | | LDL-C/(mmol·L-1) | 3.32±0.77 | 3.44±0.79 | 3.21±0.73 | 5.735 | 0.000 | | HDL-C/(mmol·L-1) | 1.23±0.28 | 1.22±0.28 | 1.24±0.28 | 1.030 | 0.303 | | Smoking/n(%) | 286 (18.7) | 159 (21.7) | 127 (15.9) | 8.334 | 0.004 | | Medication/n(%) | 275 (18.0) | 164 (22.4) | 111 (13.9) | 18.491 | 0.000 | | Antihypertensive medication | 134 (8.8) | 83 (11.3) | 51 (6.4) | 11.592 | 0.001 | | Antidiabetic medication | 55 (3.6) | 37 (5.1) | 18 (2.3) | 8.574 | 0.003 | | Lipid-lowering medication | 35 (2.3) | 22 (3.0) | 13 (1.6) | 3.208 | 0.073 | | Others | 51 (3.3) | 22 (3.0) | 29 (3.6) | 0.480 | 0.488 | | PSQI/point | 7.30±2.40 | 7.43±2.51 | 7.06±2.13 | 3.135 | 0.001 | | Poor sleep quality/n(%) | 141 (9.2) | 89 (12.1) | 52 (6.5) | 14.409 | 0.001 | | Drinking/n(%) | 904 (59.2) | 444 (60.6) | 460 (57.7) | 1.297 | 0.255 | | Physical activity/n(%) | | | | 2.969 | 0.227 | | High level | 110 (7.2) | 59 (8.1) | 51 (6.4) | | | | Moderate level | 1 138 (74.5) | 549 (75.0) | 589 (74.0) | | | | Low level | 280 (18.3) | 124 (16.9) | 156 (19.6) | | | | Dietary diversity score/point | 4.88±1.22 | 4.97±1.20 | 4.81±1.23 | 2.557 | 0.010 |
|
|
|